Who invested in SPR Therapeutics

9 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$101Mraised across 9 rounds since 2011, from 9 sources

$250KVenture$2.2MVenture$5.0MSeries A$2.9MGrant$3.9MDebt$519KDebt$1.6MGrant$25MSeries C$60MDebt

Latest round: Debt, $60MFeb 2024
Step-upi: 2.4×
Investors: 4

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201320152017201920212023

$250KVenture$2.2MVenture$5.0MSeries A$2.9MGrant$3.9MDebt$519KDebt$1.6MGrant$25MSeries C$60MDebt

First round: Venture, $250K
Biggest round: $60M
Usual gap between rounds: 13 months

The rounds

Feb 2024
Debt$60M
No investor was named in the report.
Source recordedSEC filing: $26M sold, first sale Jan 2024
Sept 2017
Series C$25M
No investor was named in the report.
Reported by FinSMEsSEC filing: $15M sold, first sale Sept 2017
Aug 2015
Grant$1.6M
No investor was named in the report.
From a historical funding recordSEC filing: $519K sold, first sale Jul 2015
Jul 2015
Debt$519K
No investor was named in the report.
From a historical funding recordSEC filing: $519K sold, first sale Jul 2015
Jun 2014
Debt$3.9M
No investor was named in the report.
From a historical funding recordSEC filing: $3.9M sold, first sale Nov 2013
May 2014
Grant$2.9M1 new
- Small Business Innovation Research
From a historical funding recordSEC filing: $3.9M sold, first sale Nov 2013
Jan 2013
Series A$5.0M2 new
- NDI Healthcare Fund
- Public Square Partners
Reported by finsmes.com
Jan 2012
Venture$2.2M
No investor was named in the report.
Reported by sec.govSEC filing: $2.2M sold, first sale Oct 2011
Apr 2011
Venture$250K1 new
- JumpStart
Reported by finsmes.com

Founders and team

From SPR Therapeutics's own website and the SEC filings it signed: 1 founder, 11 on the team.

Maria E. BennettPresident, CEO, and FounderNamed on its 2024 Form D

Devin SellVice President, Engineering and Manufacturing
Kathryn StagerVice President, Quality, Regulatory, and Corporate Compliance
Laurie CiganVice President, Customer Engagement
Michelle McDonaldVice President, Marketing
David YoungbergChief Commercial Officer
Nicolas J. ValerianiDirector
Ben J. AustinExecutive Officeri
Geoffrey B. ThropeChairman
Josh J. BoggsExecutive Officeri
Michael J. ChuisanoDirector
Robert B. BlankenshipDirector

On the board, as filediNicholas J. Valeriani

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2012Series A2013Grant2014Debt2014Debt2015Grant2015Series C2017Debt2024

JumpStart

Small Business Innovation ResearchNDI Healthcare FundPublic Square Partners

Everyone who backed them

JumpStartVC firm1round

Small Business Innovation ResearchGovernment1round

NDI Healthcare Fundno record of our own yet1round

Public Square Partnersno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists SPR Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

NDI MedicalVC firmPer its own site